by Co-Diagnostics | Sep 25, 2017 | News Release
SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today that it will be presenting at the Third Annual Robins Equity Research...
by Co-Diagnostics | Sep 7, 2017 | News Release
SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today that CEO Dwight Egan will represent Co-Diagnostics as a Presenting...
by Co-Diagnostics | Sep 5, 2017 | News Release
SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, and MEDCIS Pathlabs India Pvt. Ltd., have agreed to the terms of a purchase agreement for...
